ArticleClinical cancer research : an official journal of the American Association for Cancer Research2012

Connexin 47 mutations increase risk for secondary lymphedema following breast cancer treatment.

David N Finegold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.